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Abstract
Background: CYP1B1 is the most commonly mutated gene in primary congenital glaucoma (PCG). This study was
undertaken to identify mutations in CYP1B1 in the Western region of Saudi Arabia.
Methods: Blood of patients who had typical findings of PCG, were screened by direct sequencing of all coding
exons and splice junctions of the CYP1B1 gene.
Results: 34 patients were studied; 18 patients belonged to 8 families, and 16 patients were non-familial, isolated
PCG. Consanguinity was found in 27/34 (79.4%) of cases. All patients were diagnosed to have bilateral PCG at birth
except one child, who had glaucoma in the right eye. More males (61.8%) were affected than females (38.2%).
79.4% (27/34) of patients were solved with pathogenic mutations and 20.6% (7/34) remained unsolved. Of the
solved ones, 22.2% (6/27) of patients carry a pathogenic allele on one allele while the other allele remained yet to
be determined. Direct sequencing of exon 2 revealed two pathogenic variants (p.Gly61Glu, p.Glu229Lys). P.Gly61Glu
substitution was found both homozygously in 63% (17/27) of cases, and heterozygously in one patient. P.Glu229Lys
variant was found heterozygous in 3.7% (1/27) of cases. One pathogenic variant (p.Arg469Trp) was found in exon 3,
and is present homozygously in 14.8% (4/27) of cases while four patients have this variant heterozygously. All
mutations were reported previously in the Saudi population, except p.Glu229Lys. Severe cases were associated with
p.Gly61Glu, and p.Arg469Trp in 50% and 30% of ten patients respectively.
Conclusions: This study confirms that CYP1B1 mutations are the most frequent cause of PCG in the Saudi
population, with p.Gly61Glu being the major disease-associated mutation. P.Glu229Lys is a newly discovered
mutation in our PCG patients. Patient lacking mutation in CYP1B1 gene seems likely, to have another genetic loci
involved in the pathogenesis of the disease, and need further study. Genetic studies of recessive diseases such as
PCG is important in consanguineous populations, since it will increase awareness and allows genetic counseling to
be offered to patients and their relatives. This will not only reduce the disease to be inherited to future generations,
but will also reduce the disease burden in the community.
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Background
Primary congenital glaucoma (PCG) refers to a glaucoma
occurring within the first 3 years of life, due to isolated
trabeculodysgenesis [1]. It is relatively common in Saudi
Arabia (SA), with an estimated incidence of 1: 2500 live
births, secondary to a high prevalence of consanguinity in
Saudi families [2]. It is the second most common cause of
blindness in schools of the blind in SA [3]. The congenital
glaucoma registry at King Khaled Eye Specialist Hospital
showed that PCG geographic distributions in SA is:
south region (27.8%), western province (23.6%), central
region (22.2%), eastern province (11.1%), and north
province (9%) [4].
The link between PCG and gene abnormalities is the ini-
tial step in the establishment of the pathophysiology of the
disease. Three previous major studies [5-7] were con-
ducted in SA, to identify the abnormal genes associated
with PCG. So far CYP1B1 was the only gene found to be
associated with bilateral PCG in consanguineous Saudi
Arabian families. CYP1B1 mutations were identified in
96% of cases of the study described by Bejjani et al. [6] and
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in 75.9% of cases of the study described by Abu-Amero
et al. [7]. Unilateral PCG were studied by Khan et al. [8]
but was not associated with CYP1B1 mutations. Expatriates
were excluded from all previous gene studies [4-8].
This study was conducted to identify CYP1B1 muta-
tions in Saudi PCG patients with various ethnic back-
grounds, and to identify those patients who carry novel
mutations. Patients were collected at King Abdulaziz
University Hospital, one of the major hospitals in the
Western province of Saudi Arabia and a main referral
centre for congenital glaucoma in the province.
Methods
Patients and clinical data
The study adhered to the guidelines of the Declaration of
Helsinki and was approved by King Abdulaziz University
Research ethics committee (Reference No. 922–12).
After signed informed consents were obtained, blood
samples were collected for DNA isolation from 34 pa-
tients with PCG.
Patients were recruited from the glaucoma clinic at King
Abdulaziz University Hospital (KAUH) and the pediatric
ophthalmology clinic at King Fahd Armed Forces Hospital
(KFAFH), in Jeddah, Kingdom of Saudi Arabia. The diag-
nosis of PCG was established by the following signs: (1) in-
creased intraocular pressure (IOP) (>21 mmHg), (2) cornea
diameter (>10 mm) and changes (oedema, Haab’s striae,
scar), (3) optic nerve glaucomatous cupping, and by the
following symptoms: photophobia, epiphora, and/or ble-
phrospasm [1]. The medical history of all participants was
taken and the family pedigrees were drawn. Patients with
other ocular and systemic abnormalities were excluded.
Molecular genetic analysis
Primers were designed for the two coding exons and
splice site junctions of the CYP1B1 gene using Primer 3
(primer sequences and PCR conditions are available on
request). PCR products were visualized on 2% agarose
gel and purified with PCR clean-up purification plates
(NucleoFast® 96 PCR, MACHEREY-NAGEL, Germany),
according to the manufacturer’s protocol. Purified PCR
products were analyzed by Sanger sequencing in both
directions using both forward and reverse primers in an
automated DNA sequencer (Big Dye Terminator, version
3 on a 3730 DNA analyzer; Applied Biosystems, Inc.,
Foster City, CA). Sequencing results were aligned with
the reference sequence (obtained from the hg19 human
genome build) and analyzed using Vector NTI Advance
(TM) 2011 software (Invitrogen). In addition, the pathogen-
icity of CYP1B1 missense variants was evaluated by publi-
cally available in silico tools including PhyloP, Grantham,
PolyPhen2, and SIFT.
Data collection and statistical analysis
Data were collected from the medical records in a special
form and then entered and stored in computer Microsoft
ward. Graph Prism 5 software (GraphPad Software Inc, La
Jolla, Ca USA) was used to analyze the data. Frequency
distribution tables were used to present the data. Mean,
standard deviation and (student’s) t-test were used to com-
pare continuous variables.
All tests were two sided and at a 5% level of statistical
significance. Fisher’s exact test also used to compare the
real values of native and non-native Saudi groups.
Results
Demographic and medical data
Our study included 34 PCG patients: 23 patients from
KAUH and 11 patients from KFAFH. 18 patients belonged
to 8 families with consanguineous parents, while9 patients
were unrelated, non-familial, isolated PCG cases belonging
to consanguineous parents. 7 patients were unrelated, non-
familial, isolated PCG belonging to non-consanguineous
parents. Consanguinity was reported in 27/34 (79.4%) of
cases.
All 34 patients were diagnosed to have bilateral PCG at
birth except one child, who had glaucoma only in the right
eye. More males (21/34) were affected than females (13/34).
At presentation, the mean IOP +/− standard deviation (SD)
was 30.48+/−6.93 (range 20 – 47) mmHg, the mean corneal
diameter +/− SD was 12.71 +/−1.26 (range 10 – 17) mm.
The mean cupping +/− SD and mean refraction +/− SD of
23 eyes with clear cornea was 0.47 +/− 0.29 (range 0.1 -
1.0), and - 4.92 +/− 5 (range +2.3 to −16) D respectively.
Twenty three cases were native Saudi, of which 21 (91%)
were positive for CYP1B1 mutations, and 2 (9%) were ne-
gative. Eleven patients were non-native Saudi, originating
from Yemen (4), Sudan (3), Afghanistan (2), Burma (1), and
Syria (1). Of the non-native cases, 6 (54.5%) were positive
for CYP1B1 mutations, and 5 (45.5%) were negative. Over-
all 27/34 (79.4%) cases carried CYP1B1 mutations and
20.6% (7/34) patients remained unsolved. Table 1, present a
comparison of demographic, medical and CYP1B1 muta-
tions between native and non-native Saudis. No significant
differences were observed between the 2 groups, except for
the mean C/D ratio, which was higher in the non-native
Saudi group.
Ten patients were classified to have severe glaucoma
on presentation (based on IOP level, corneal diameter
and clarity) according to Al-Hazmi et al. [9] classifica-
tion. 5 (50%) patients were associated with G61E, and
3 (30%) patients with R469W mutations Table 2.
CYP1B1 mutation analysis
DNA samples of all patients were screened for mutations
in the CYP1B1 gene. Pathogenic variants were detected in
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CYP1B1 gene in 27 patients. 77.8% (21/27) patients were
completely solved with pathogenic mutations, while 22.2%
(6/27) patients were carrying a pathogenic allele on one al-
lele while the other allele remained yet to be known. Dir-
ect sequencing of exon 2 revealed two pathogenic variants
(c.182G > A: p.Gly61Glu, and c.685G >A: p.Glu229Lys).
The p.Gly61Glu substitution was found homozygously in
63% (17/27) patients, of which 10 cases belong to 4 con-
sanguineous families. The p.Glu229Lys variant was found
heterozygously in 3.7% (1/27) of cases Table 3.
Similarly, one pathogenic variant (c.1405C > T: p.
Arg469Trp) was detected in exon 3. The p.Arg469Trp
was found in 29.6% (8/27) patients. The p.Arg469Trp sub-
stitution was found homozygously in four patients belong-
ing to two consanguineous families.
The probable pathogenic mutations of the 22.2% (6/27)
patients were, p.Arg469Trp in four patients, p.Gly61Glu
in one patient and p.Glu229Lys in one patient, heterozy-
gously. These six patients might have a second variant in
the same gene that lies in the noncoding region i.e. intron
or promoter Table 3.
In addition to those pathogenic variants, 6 other com-
mon SNPs (rs2617266, rs10012, rs1056827, rs9341249,
rs4986888 and rs1056837) were also found either homo-
zygously and heterozygously, that were not predicted to
be pathogenic Table 3.
Discussion
The populations of the Arabian Peninsula descend from
a small number of founders. Their descendants estab-
lished various tribes that dispersed across the kingdom.
Therefore, the majority of native Saudi Arabians living
today have common ancestors [5]. This is may be true in
all parts of SA except the Western region, where the
population consists of a different ethnic groups due to
the presence of the two holy cities, Makkah and Madinah,
and immigration of people from Arabic and Islamic coun-
tries to this region over the last 14 centuries. Jeddah is the
sea port of the two holy cities, and thus also has a popula-
tion with a high cultural and ethnical diversity. Non-native
Saudi PCG patients were excluded from all previously
published gene studies, and only conducted on native pa-
tients from various tribes and regions of SA [4-8]. To the
best of our knowledge this is the only gene study in SA,
which addresses the effect of ethnicity on gene anomalies
in PCG.
The CYP1B1 gene was selected to screen for muta-
tions in our PCG patients, since it was considered the
main candidate gene for PCG in Saudi Arabia. CYP1B1
mutations were found in 79.4% of our patients, which is
higher than that reported by Abu-Amero et al. [7] and
lower than that reported by Bejjani et al. [6].
We detected CYP1B1 mutations in 91% and 54.5% of
native and non-native Saudi Arabian PCG patients, re-
spectively. This difference in rate of mutations could be
secondary to the lower consanguinity rate in the non-
native Saudi population (54.6%) compared to the native
population (91.3%). The rate of CYP1B1 mutations in our
non-native Saudi cases is low and comparable to popula-
tions with low consanguinity rates like India (44%) [10]
and Brazil (50%) [11]. In addition, the high rate of CYP1B1
mutations in the native Saudi PCG cases may be explained
by the population structure. Since the native Saudi popula-
tion descended from a limited number of founders, it is
likely that one of a small number of founder mutations
have arisen that explain the majority of the cases among
Table 1 Comparison of demographic data and CYP1B1 mutations between native and non-native Saudi patients
No. of
patients
Gender (%) Affected
eyes
Cons
(%)
Mean IOP
(+/−SD) mmHg
Mean corneal diameter
(+/−SD) mm
Mean C/D
(+/−SD)
Mutation
(%)
M F R L R L R L R L
Native Saudi 23 14 (60.7) 9 (39.1) 23 23 21 (91.3) 29.2 (4.9) 30.9 (6.9) 12.5 (1.3) 12.7 (1.6) 0.3 (0.3) 0.4 (0.3) 21(91)
Non-native Saudi 11 7 (63.6) 4 (36.4) 11 10 6 (54.6) 31.7 (9.07) 31.3 (9.04) 12.8 (0.7) 12.8 (0.9) 0.7 (0.2) 0.7 (0.3) 6 (54.5)
P Value *1 *1 *1 *1 *0.4 **.302 **.887 **.481 **.849 **.0005 **.0153 **0.4
M-Male, F-Female, R-Right eye, L-Left eye, IOP-Intraocular pressure, C/D-Cup to Disc ratio, Cons = consanguinity, *Fisher’s exact test, **t-student test.
Table 2 Correlation between CYP1B1 mutations and Severity of PCG in native (23) and non-native (11) Saudi
Severity
Mild Moderate Severe
None G61E R469W E229K None G61E R469W E229K None G61E R469W E229K
No. of Native Saudi (%) 1 (4.4) 6 (26.1) 2 (8.7) 0 (0) 0 (0) 5 (21.7) 2 (8.7) 0 (0) 1 (4.4) 4 (17.4) 2 (8.7) 0 (0)
No. of Non-Native Saudi (%) 2 (18.2) 1 (9.1) 0 (0) 0 (0) 2 (19.2) 1 (9.1) 1 (9.1) 1 (9.1) 1 (9.1) 1 (9.1) 1 (9.1) 0 (0)
Total (%) 3 (8.8) 7 (20.6) 2 (5.9) 0 (0) 2 (5.9) 6 (17.7) 3 (8.8) 1 (2.9) 2 (5.9) 5 (15.8) 3 (8.8) 0 (0)
[9] Mild: (IOP < 25 mmHg, Corneal diameter < 13 mm, Clear cornea).
Moderate: (IOP = 25-35 mmHg, corneal diameter = 13-14.5 mm, hazy cornea).
Severe: (IOP > 35 mmHg, corneal diameter > 14.5 mm, cloudy cornea).
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the native Saudi populations. Two of the pathogenic vari-
ants (p.Gly61Glu, p.Arg469Trp) identified in our cases
were previously reported in the literature in PCG patients
of various populations (ethnic groups), including native
Saudi Arabians [5-7]. The Gly61Glu mutation is the most
frequent mutation in the Saudi patients of our current
study as well as in patients from Kuwait. Both SA and
Kuwait share a common genetic background because of
the neighborhood and frequent migration routes between
the two populations [12]. We identified a missense muta-
tion (p.Glu229Lys) in one of our non-native Saudi PCG
patients. This patient’s family is originally from Burma.
This mutation has not been reported previously in native
Saudi Arabian PCG patients [5-7], but it has been reported
in Turkish [13], Indian [10], Iranian [14] patients, and in
an index patient of family from Oman in heterozygous
manner [15].
In a previous study of CYP1B1 analysis by Bejjani et al.
[6] in PCG patients from SA a haplotype was con-
structed for the six SNPs. We also constructed haplo-
types ie C/C/G/G/T/A using the same SNPs which
includes one intronic c.-1-12C > T and five exonic SNPs
i.e. c.142C > G; R48G, c.355G > T; A119S, c.1294C > G;
V432L, c.1347T > C; D449D and c.1358A > G; N453S. In
their study they had observed that this distinctive haplo-
type is associated with the five different mutations and
we also saw a same haplotype C/G/G/T/A in case of the
two mutations Gly61Glu and Arg469Trp in 27 patients.
This same haplotype C/C/G/G/T/A was associated with
at least seven separate mutations and appears to be com-
mon in all the individuals carrying the most frequent mu-
tation, 4340delG in CYP1B1 in Brazilian PCG patients
[11,16]. However in the 7 patients which remained un-
solved with CYP1B1 in the current study, 4 patients had
this haplotype T/G/T/C/C/A while three individuals were
heterozygous for all these five SNPs. Bejjani et al. [6] also
found that the three families unsolved with CYP1B1 muta-
tions has a heterozygous haplotype for these five SNPs. It
seems likely, that individuals lacking haplotype C/C/G/G/
T/A have another genetic loci involved in the pathogenesis
of PCG. We are currently exploring this possibility.
In the literature, there has not been a consistent correl-
ation between the severity of PCG and presence and types
of CYP1B1 mutations [17]. Hollander et al. [18] found a
correlation between the type of CYP1B1 mutations and
the severity of glaucoma on the basis of anterior chamber
angle histological changes and difficulty in controlling
IOP. Panicker et al. [19] found that severe cases (using se-
verity index) of PCG associated with ins376A (100%),
E229K (80%), E368H (72%), G61E (66.7%), and P193L
(62.5%). The severity of PCG in our patients was assessed
on the basis of clinical assessment of IOP level, corneal
diameter, and corneal clarity at the time of presentation.
We did find severe cases of PCG associated with two mu-
tations, G61E (50%), and R469W (30%), in ten of our
patients.
Conclusions
This study confirms that CYP1B1 mutations are the most
frequent cause of PCG in the Saudi Arabian population,
with p.Gly61Glu being the major disease-associated allele.
The p.Glu229Lys is a new mutation in Saudi Arabian PCG
patients. Genetic studies of recessive diseases such as PCG
is important in consanguineous populations, since it will
increase awareness and allows genetic counseling to be of-
fered to patients and their relatives. This will not only re-
duce the disease to be inherited to future generations, but
will also reduce the disease burden in the community.
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